Hangzhou Biotest Biotech was granted emergency use authorization by the FDA for its SARS-CoV-2 antibodies test, according to postings on the FDA’s website.
- Phosphorus Diagnostics gets an EUA for its Covid-19 RT-qPCR test
- Vibrant America Clinical gets an EUA for its SARS-CoV-2 antibodies test
- NOTE: The three EUAs were issued June 4
To view the source of this information click
To contact the reporter on this story:
To contact the editors responsible for this story:
© 2020 Bloomberg L.P. All rights reserved. Used with permission.